Advertisement

Index by author

October 01, 1984; Volume 231,Issue 1

A

  1. Asano, T

    1. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
      T Asano and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 141-145;

  2. Assens, F

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

B

  1. Baghdoyan, H A

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

  2. Bailey, J C

    1. Adenosine and prostacyclin independent electrophysiological effects of dipyridamole in guinea-pig papillary muscles and canine cardiac Purkinje fibers.
      D P Rardon, R J Kovacs and J C Bailey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 206-213;

  3. Baumann, P A

    1. Carbamazepine decreases catecholamine turnover in the rat brain.
      P C Waldmeier, P A Baumann, B Fehr, P De Herdt and L Maitre
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 166-172;

  4. Bayorh, M H

    1. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
      M H Bayorh, Z Zukowska-Grojec, I J Kopin and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 85-90;

  5. Bennett, W F

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  6. Bhatnagar, R

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

  7. Bianchi, C P

    1. Effect of diazepam on calcium translocation during physiological muscle fatigue.
      C P Bianchi and S R Narayan
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 197-205;

  8. Bolger, G T

    1. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
      R A Janis, J G Sarmiento, S C Maurer, G T Bolger and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 8-15;

  9. Borison, H L

    1. Peripheral and central actions of sodium azide on circulatory and respiratory homeostasis in anesthesized cats.
      P V Kaplita, H L Borison, L E McCarthy and R P Smith
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 189-196;

  10. Breese, G R

    1. Distribution of methylphenidate and p-hydroxymethylphenidate in rats.
      K S Patrick, K R Ellington and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 61-65;

  11. Brown, D R

    1. Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
      D R Brown and R J Miller
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 114-119;

  12. Builder, S

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

C

  1. Cannon, J G

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

  2. Carter, W H

    1. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
      E Tagashira, J F Kachur, W H Carter and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 97-101;

  3. Cline, W H

    1. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
      H Kawasaki, W H Cline and C Su
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 23-32;

  4. Clouet, D H

    1. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum.
      N Yonehara and D H Clouet
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 38-42;

  5. Collen, D

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

D

  1. De Cock, F

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  2. De Herdt, P

    1. Carbamazepine decreases catecholamine turnover in the rat brain.
      P C Waldmeier, P A Baumann, B Fehr, P De Herdt and L Maitre
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 166-172;

  3. DeLander, G E

    1. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
      G E DeLander, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 91-96;

  4. Dewey, W L

    1. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
      E Tagashira, J F Kachur, W H Carter and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 97-101;

E

  1. Ellington, K R

    1. Distribution of methylphenidate and p-hydroxymethylphenidate in rats.
      K S Patrick, K R Ellington and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 61-65;

F

  1. Fadul, S

    1. Adenosine: a modulator of gastric acid secretion in vivo.
      J G Gerber, S Fadul, N A Payne and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 109-113;

  2. Fehr, B

    1. Carbamazepine decreases catecholamine turnover in the rat brain.
      P C Waldmeier, P A Baumann, B Fehr, P De Herdt and L Maitre
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 166-172;

  3. Feuerstein, G

    1. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
      M H Bayorh, Z Zukowska-Grojec, I J Kopin and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 85-90;

  4. Fleming, W W

    1. Cellular potentials, electrogenic sodium pumping and sensitivity in guinea-pig atria.
      J C Schulz, W W Fleming, D P Westfall and R Millecchia
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 181-188;

  5. Flynn, J

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

  6. Fowler, B A

    1. Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein.
      P L Goering and B A Fowler
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 66-71;

  7. Fung, H L

    1. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
      R A Morrison and H L Fung
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 124-130;

G

  1. Garzón, J

    1. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
      J Garzón, P Sánchez-Blázquez and N M Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 33-37;

  2. Gerber, J G

    1. Adenosine: a modulator of gastric acid secretion in vivo.
      J G Gerber, S Fadul, N A Payne and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 109-113;

  3. Goering, P L

    1. Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein.
      P L Goering and B A Fowler
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 66-71;

H

  1. Haggstrom, G D

    1. Histamine H1 and H2 effects on gastric acid and pepsin, heart rate and blood pressure in humans.
      G D Haggstrom and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 120-123;

  2. Halpert, J

    1. Selective inhibition by chloramphenicol of cytochrome P-450 isozymes in rat lung and liver involved in the hydroxylation of n-hexane.
      B M Näslund and J Halpert
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 16-22;

  3. Hicks, P E

    1. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
      I C Medgett, P E Hicks and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 159-165;

  4. Hidaka, H

    1. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
      T Asano and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 141-145;

  5. Hirschowitz, B I

    1. Histamine H1 and H2 effects on gastric acid and pepsin, heart rate and blood pressure in humans.
      G D Haggstrom and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 120-123;

  6. Hobson, J A

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

I

  1. Ilhan, M

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

J

  1. Jaim-Etcheverry, G

    1. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
      M E Landa, M C Rubio and G Jaim-Etcheverry
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 131-136;

  2. Janis, R A

    1. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
      R A Janis, J G Sarmiento, S C Maurer, G T Bolger and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 8-15;

  3. Johnson, C L

    1. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
      D G Sawutz, K Kalinyak, J A Whitsett and C L Johnson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 1-7;

K

  1. Kachur, J F

    1. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
      E Tagashira, J F Kachur, W H Carter and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 97-101;

  2. Kalinyak, K

    1. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
      D G Sawutz, K Kalinyak, J A Whitsett and C L Johnson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 1-7;

  3. Kamen, B A

    1. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.
      G R Krakower and B A Kamen
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 43-47;

  4. Kaplita, P V

    1. Peripheral and central actions of sodium azide on circulatory and respiratory homeostasis in anesthesized cats.
      P V Kaplita, H L Borison, L E McCarthy and R P Smith
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 189-196;

  5. Kawasaki, H

    1. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
      H Kawasaki, W H Cline and C Su
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 23-32;

  6. Kopin, I J

    1. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
      M H Bayorh, Z Zukowska-Grojec, I J Kopin and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 85-90;

  7. Kovacs, R J

    1. Adenosine and prostacyclin independent electrophysiological effects of dipyridamole in guinea-pig papillary muscles and canine cardiac Purkinje fibers.
      D P Rardon, R J Kovacs and J C Bailey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 206-213;

  8. Krakower, G R

    1. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.
      G R Krakower and B A Kamen
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 43-47;

  9. Kreisberg, J I

    1. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C.
      D W Schwertz, J I Kreisberg and M A Venkatachalam
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 48-55;

  10. Kwok, Y C

    1. Photoaffinity labeling of the rat isolated portal vein: determination of affinity constants and "spare" receptors for angiotensins II and III.
      Y C Kwok and G J Moore
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 137-140;

L

  1. Lai, C M

    1. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 72-79;
    2. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 80-84;

  2. Landa, M E

    1. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
      M E Landa, M C Rubio and G Jaim-Etcheverry
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 131-136;

  3. Langer, S Z

    1. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
      I C Medgett, P E Hicks and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 159-165;

  4. Lee, N M

    1. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
      J Garzón, P Sánchez-Blázquez and N M Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 33-37;

  5. Lee, T

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

  6. Levy, G

    1. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 72-79;
    2. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 80-84;

  7. Long, J P

    1. TL-350, an ergoline derivative with dopamine receptor agonist properties.
      M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon and T Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 56-60;

M

  1. Maitre, L

    1. Carbamazepine decreases catecholamine turnover in the rat brain.
      P C Waldmeier, P A Baumann, B Fehr, P De Herdt and L Maitre
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 166-172;

  2. Marafino, B J

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  3. Maurer, S C

    1. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
      R A Janis, J G Sarmiento, S C Maurer, G T Bolger and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 8-15;

  4. McCarley, R W

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

  5. McCarthy, L E

    1. Peripheral and central actions of sodium azide on circulatory and respiratory homeostasis in anesthesized cats.
      P V Kaplita, H L Borison, L E McCarthy and R P Smith
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 189-196;

  6. McKay, D B

    1. Selective inhibition of cholinergic receptor-mediated 45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine.
      D B McKay and A S Schneider
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 102-108;

  7. Medgett, I C

    1. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
      I C Medgett, P E Hicks and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 159-165;

  8. Millecchia, R

    1. Cellular potentials, electrogenic sodium pumping and sensitivity in guinea-pig atria.
      J C Schulz, W W Fleming, D P Westfall and R Millecchia
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 181-188;

  9. Miller, R J

    1. Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
      D R Brown and R J Miller
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 114-119;

  10. Monaco, A P

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

  11. Moore, G J

    1. Photoaffinity labeling of the rat isolated portal vein: determination of affinity constants and "spare" receptors for angiotensins II and III.
      Y C Kwok and G J Moore
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 137-140;

  12. Morrison, R A

    1. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
      R A Morrison and H L Fung
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 124-130;

N

  1. Nagase, H

    1. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
      H Ozaki, H Nagase and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 153-158;

  2. Narayan, S R

    1. Effect of diazepam on calcium translocation during physiological muscle fatigue.
      C P Bianchi and S R Narayan
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 197-205;

  3. Näslund, B M

    1. Selective inhibition by chloramphenicol of cytochrome P-450 isozymes in rat lung and liver involved in the hydroxylation of n-hexane.
      B M Näslund and J Halpert
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 16-22;

  4. Nies, A S

    1. Adenosine: a modulator of gastric acid secretion in vivo.
      J G Gerber, S Fadul, N A Payne and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 109-113;

O

  1. Ogez, J

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  2. Ozaki, H

    1. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
      H Ozaki, H Nagase and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 153-158;

P

  1. Patrick, K S

    1. Distribution of methylphenidate and p-hydroxymethylphenidate in rats.
      K S Patrick, K R Ellington and G R Breese
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 61-65;

  2. Payne, N A

    1. Adenosine: a modulator of gastric acid secretion in vivo.
      J G Gerber, S Fadul, N A Payne and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 109-113;

  3. Pennica, D

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  4. Portoghese, P S

    1. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
      G E DeLander, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 91-96;

R

  1. Rardon, D P

    1. Adenosine and prostacyclin independent electrophysiological effects of dipyridamole in guinea-pig papillary muscles and canine cardiac Purkinje fibers.
      D P Rardon, R J Kovacs and J C Bailey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 206-213;

  2. Rodrigo-Angulo, M L

    1. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs.
      H A Baghdoyan, A P Monaco, M L Rodrigo-Angulo, F Assens, R W McCarley and J A Hobson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 173-180;

  3. Rubio, M C

    1. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
      M E Landa, M C Rubio and G Jaim-Etcheverry
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 131-136;

S

  1. Salwa, J

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  2. Sánchez-Blázquez, P

    1. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
      J Garzón, P Sánchez-Blázquez and N M Lee
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 33-37;

  3. Sarmiento, J G

    1. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
      R A Janis, J G Sarmiento, S C Maurer, G T Bolger and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 8-15;

  4. Sawutz, D G

    1. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
      D G Sawutz, K Kalinyak, J A Whitsett and C L Johnson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 1-7;

  5. Schneider, A S

    1. Selective inhibition of cholinergic receptor-mediated 45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine.
      D B McKay and A S Schneider
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 102-108;

  6. Schulz, J C

    1. Cellular potentials, electrogenic sodium pumping and sensitivity in guinea-pig atria.
      J C Schulz, W W Fleming, D P Westfall and R Millecchia
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 181-188;

  7. Schwertz, D W

    1. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C.
      D W Schwertz, J I Kreisberg and M A Venkatachalam
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 48-55;

  8. Smith, R P

    1. Peripheral and central actions of sodium azide on circulatory and respiratory homeostasis in anesthesized cats.
      P V Kaplita, H L Borison, L E McCarthy and R P Smith
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 189-196;

  9. Stassen, J M

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  10. Su, C

    1. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
      H Kawasaki, W H Cline and C Su
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 23-32;

T

  1. Tagashira, E

    1. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
      E Tagashira, J F Kachur, W H Carter and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 97-101;

  2. Tajiri, D

    1. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
      D Collen, J M Stassen, B J Marafino, S Builder, F De Cock, J Ogez, D Tajiri, D Pennica, W F Bennett and J Salwa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 146-152;

  3. Takemori, A E

    1. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
      G E DeLander, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 91-96;

  4. Triggle, D J

    1. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
      R A Janis, J G Sarmiento, S C Maurer, G T Bolger and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 8-15;

U

  1. Urakawa, N

    1. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
      H Ozaki, H Nagase and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 153-158;

V

  1. Venkatachalam, M A

    1. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C.
      D W Schwertz, J I Kreisberg and M A Venkatachalam
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 48-55;

W

  1. Waldmeier, P C

    1. Carbamazepine decreases catecholamine turnover in the rat brain.
      P C Waldmeier, P A Baumann, B Fehr, P De Herdt and L Maitre
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 166-172;

  2. Westfall, D P

    1. Cellular potentials, electrogenic sodium pumping and sensitivity in guinea-pig atria.
      J C Schulz, W W Fleming, D P Westfall and R Millecchia
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 181-188;

  3. Whitsett, J A

    1. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
      D G Sawutz, K Kalinyak, J A Whitsett and C L Johnson
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 1-7;

Y

  1. Yacobi, A

    1. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 72-79;
    2. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
      A Yacobi, C M Lai and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 80-84;

  2. Yonehara, N

    1. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum.
      N Yonehara and D H Clouet
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 38-42;

Z

  1. Zukowska-Grojec, Z

    1. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
      M H Bayorh, Z Zukowska-Grojec, I J Kopin and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1984, 231 (1) 85-90;
Back to top

In this issue